GCAR1
/ Alberta Health Services, Canadian Cancer Trials Group
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
December 23, 2025
GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours
(clinicaltrials.gov)
- P1 | N=30 | Not yet recruiting | Sponsor: Canadian Cancer Trials Group
New P1 trial • Alveolar Soft Tissue Sarcoma • Breast Cancer • Genito-urinary Cancer • Hormone Receptor Positive Breast Cancer • Oncology • Renal Cell Carcinoma • Sarcoma • Solid Tumor • Triple Negative Breast Cancer
1 to 1
Of
1
Go to page
1